{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:56:09Z","timestamp":1780581369935,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.dsx.2020.05.050","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T11:57:27Z","timestamp":1591271847000},"page":"767-771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Managing common endocrine disorders amid COVID-19 pandemic"],"prefix":"10.1016","volume":"14","author":[{"given":"Rimesh","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2020.05.050_bib2","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, ninth ed.","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2020.05.050_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.dsx.2020.05.050_bib4","author":"Facts and Statistics"},{"key":"10.1016\/j.dsx.2020.05.050_bib5","doi-asserted-by":"crossref","first-page":"108132","DOI":"10.1016\/j.diabres.2020.108132","article-title":"COVID-19, diabetes mellitus and ACE2: the conundrum","author":"Pal","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2020.05.050_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.dsx.2020.04.049","article-title":"COVID-19 and diabetes mellitus: an unholy interaction of two pandemics","volume":"14","author":"Pal","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2020.05.050_bib7","doi-asserted-by":"crossref","first-page":"108146","DOI":"10.1016\/j.diabres.2020.108146","article-title":"Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?","author":"Pal","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2020.05.050_bib8","doi-asserted-by":"crossref","unstructured":"Banerjee M, Chakraborty S, Pal R. Diabetes self-management amid COVID-19 pandemic. Diabetes Metab Syndr Clin Res Rev [Internet]. 2020 [cited 2020 Apr 15]; Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402120300783.","DOI":"10.1016\/j.dsx.2020.04.013"},{"key":"10.1016\/j.dsx.2020.05.050_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dsx.2020.04.004","article-title":"Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2020.05.050_bib10","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.18203\/2320-6012.ijrms20182933","article-title":"Effect of early addition of hydroxychloroquine in type 2 diabetic patients inadequately controlled on metformin and sulfonylurea combination therapy","volume":"6","author":"Baidya","year":"2018","journal-title":"Int J Res Med Sci"},{"key":"10.1016\/j.dsx.2020.05.050_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.dsx.2020.04.001","article-title":"Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: guidelines for physicians","volume":"14","author":"Ghosh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.dsx.2020.05.050_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/1932296820929391","article-title":"Teleconsultation and diabetes care amid COVID-19 pandemic in India: scopes and challenges","author":"Banerjee","year":"2020","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1016\/j.dsx.2020.05.050_bib13","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-20-0445","article-title":"Endocrinology in the time of COVID-19: management of hyper- and hypo- thyroidism","author":"Boelaert","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.dsx.2020.05.050_bib14","unstructured":"BTA\/SFE Statement regarding issues specific to thyroid dysfunction during the COVID -19 pandemic. [cited 2020 May 20]; Available from: https:\/\/www.british-thyroid-association.org\/sandbox\/bta2016\/management-of-thyroid-dysfunction-during-covid-19_final.pdf."},{"key":"10.1016\/j.dsx.2020.05.050_bib15","unstructured":"AACE Position statement: coronavirus (COVID-19) and people with thyroid disease. [Internet]. [cited 2020 May 20]. Available from: https:\/\/www.aace.com\/recent-news-and-updates\/aace-position-statement-coronavirus-covid-19-and-people-thyroid-disease."},{"key":"10.1016\/j.dsx.2020.05.050_bib16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/clinem\/dgz006","article-title":"Increased infection risk in Addison\u2019s disease and congenital adrenal hyperplasia","volume":"105","author":"Tresoldi","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2020.05.050_bib17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/EJE-12-0879","article-title":"Increased use of antimicrobial agents and hospital admission for infections in patients with primary adrenal insufficiency: a cohort study","volume":"168","author":"Smans","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.dsx.2020.05.050_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial","volume":"6","author":"Isidori","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.dsx.2020.05.050_bib19","unstructured":"Arlt W, Baldeweg SE, Pearce SHS, Simpson HL. Endocrinology in the time of COVID-19: management of adrenal insufficiency. Eur J Endocrinol [Internet]. 2020 [cited 2020 May 26]; Available from: https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/aop\/eje-20-0361\/eje-20-0361.xml."},{"key":"10.1016\/j.dsx.2020.05.050_bib20","article-title":"COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency","author":"Isidori","year":"2020","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.dsx.2020.05.050_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41574-019-0185-7","article-title":"Adrenal function and dysfunction in critically ill patients","volume":"15","author":"T\u00e9blick","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.dsx.2020.05.050_bib22","unstructured":"AACE Position statement: coronavirus (COVID-19) and people with adrenal insufficiency and Cushing\u2019s syndrome. [Internet]. [cited 2020 May 22]. Available from: https:\/\/www.aace.com\/recent-news-and-updates\/aace-position-statement-coronavirus-covid-19-and-people-adrenal."},{"key":"10.1016\/j.dsx.2020.05.050_bib23","unstructured":"Newell-Price J, Nieman L, Reincke M, Tabarin A. Endocrinology in the time of COVID-19: management of Cushing\u2019s syndrome. Eur J Endocrinol [Internet]. 2020 [cited 2020 May 27]; Available from: https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/aop\/eje-20-0352\/eje-20-0352.xml."},{"key":"10.1016\/j.dsx.2020.05.050_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/postgradmedj-2020-137742","article-title":"COVID-19 and non-communicable diseases","author":"Pal","year":"2020","journal-title":"Postgrad Med"},{"key":"10.1016\/j.dsx.2020.05.050_bib25","doi-asserted-by":"crossref","unstructured":"Patel ZM, Fernandez-Miranda J, Hwang PH, Nayak JV, Dodd R, Sajjadi H, et\u00a0al. Letter: precautions for endoscopic transnasal skull base surgery during the COVID-19 pandemic. Neurosurgery [Internet]. 2020 [cited 2020 May 27]; Available from: https:\/\/academic.oup.com\/neurosurgery\/advance-article\/doi\/10.1093\/neuros\/nyaa125\/5820367.","DOI":"10.1093\/neuros\/nyaa125"},{"key":"10.1016\/j.dsx.2020.05.050_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/EJE-17-0886","article-title":"Hepatic safety of ketoconazole in Cushing\u2019s syndrome: results of a Compassionate Use Programme in France","volume":"178","author":"Young","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.dsx.2020.05.050_bib27","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing\u2019s syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2020.05.050_bib28","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1210\/jc.2016-2221","article-title":"Exploring inpatient hospitalizations and morbidity in patients with adrenal insufficiency","volume":"101","author":"Stewart","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2020.05.050_bib29","doi-asserted-by":"crossref","unstructured":"Kaiser UB, Mirmira RG, Stewart PM. Our response to COVID-19 as endocrinologists and diabetologists. J Clin Endocrinol Metab [Internet]. 2020 [cited 2020 Apr 16];105. Available from: https:\/\/academic.oup.com\/jcem\/article\/doi\/10.1210\/clinem\/dgaa148\/5814115.","DOI":"10.1210\/clinem\/dgaa148"},{"key":"10.1016\/j.dsx.2020.05.050_bib30","unstructured":"Fleseriu M, Karavitaki N, Dekkers OM. Endocrinology in the time of COVID-19: management of pituitary tumours. Eur J Endocrinol [Internet]. 2020 [cited 2020 May 27]; Available from: https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/aop\/eje-20-0473\/eje-20-0473.xml."},{"key":"10.1016\/j.dsx.2020.05.050_bib31","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/er.2015-1042","article-title":"Pituitary apoplexy","volume":"36","author":"Briet","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.dsx.2020.05.050_bib32","doi-asserted-by":"crossref","unstructured":"Mitchell F. Vitamin-D and COVID-19: do deficient risk a poorer outcome? Lancet Diabetes Endocrinol [Internet]. 2020 [cited 2020 May 27]; Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301832.","DOI":"10.1016\/S2213-8587(20)30183-2"},{"key":"10.1016\/j.dsx.2020.05.050_bib33","unstructured":"Ebadi M, Montano-Loza AJ. Perspective: improving vitamin D status in the management of COVID-19. Eur J Clin Nutr [Internet]. 2020 [cited 2020 May 27]; Available from: http:\/\/www.nature.com\/articles\/s41430-020-0661-0."},{"key":"10.1016\/j.dsx.2020.05.050_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.dsx.2020.05.050_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jbmr.3284","article-title":"High-intensity resistance and impact training improves bone mineral density and physical function in postmenopausal women with osteopenia and osteoporosis: the LIFTMOR randomized controlled trial: heavy lifting improves BMD IN osteoporosis","volume":"33","author":"Watson","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.dsx.2020.05.050_bib36","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00198-003-1423-2","article-title":"Efficacy of home-based exercise for improving quality of life among elderly women with symptomatic osteoporosis-related vertebral fractures","volume":"14","author":"Papaioannou","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.dsx.2020.05.050_bib37","doi-asserted-by":"crossref","unstructured":"Girgis CM, Clifton-Bligh RJ. Osteoporosis in the age of COVID-19. Osteoporos Int [Internet]. 2020 [cited 2020 May 27]; Available from: http:\/\/link.springer.com\/10.1007\/s00198-020-05413-0.","DOI":"10.1007\/s00198-020-05413-0"},{"key":"10.1016\/j.dsx.2020.05.050_bib38","unstructured":"COVID-19 and osteoporosis. Acessed April 15, 2020. [Internet]. Available from: https:\/\/www.iofbonehealth.org\/news\/covid-19-and-osteoporosis."},{"key":"10.1016\/j.dsx.2020.05.050_bib39","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-20-0385","article-title":"Endocrinology in the time of COVID-19: management of calcium disorders and osteoporosis","author":"Gittoes","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.dsx.2020.05.050_bib40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4103\/2230-8210.95763","article-title":"Do we need sick-day guidelines for hypoparathyroidism?","volume":"16","author":"Bhadada","year":"2012","journal-title":"Indian J Endocrinol Metab"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120301697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120301697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:17:07Z","timestamp":1761729427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402120301697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1871402120301697"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2020.05.050","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing common endocrine disorders amid COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2020.05.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}